Vertaling van "patch 3-month course " (Nederlands → Frans) :

Treatment (both NRT and bupropion) lasts at least 1 month Retail price of NRT gum: not reported Retail price of NRT patch (3-month course): €354.54 (€, 2001) Retail price of NRT nasal spray (3-months course): €743.02 3% (range 0-5% in sensitivity analysis)
Treatment (both NRT and Buproprion) lasts at least 1 month Retail price of NRT gum: not reported Retail price of NRT patch (3-month course): €354.54 (€, 2001) Retail price of NRT nasal spray (3-months course): €743.02 3% (range 0-5% in sensitivity analysis)

2000 US$ Average retail price of NRT gum (12-week course): US$218.78 Average retail price of NRT patch (8-week course): US$154.36 Average retail price of bupropion (8-week course): US$201.39 Pharmacist time (5 hours of intervention, US$35/hr): US$175 Technician support (2 hours, US$5/hr): US$10 Material costs: US$5 0%
2000 US$ Average retail price of NRT gum (12-week course): US$218.78 Average retail price of NRT patch (8-week course): US$154.36 Average retail price of Buproprion (8-week course): US$201.39 Pharmacist time (5 hours of intervention, US$35/hr): US$175 Technician support (2 hours, US$5/hr): US$10 Material costs: US$5 0%

Spontaneous cessation rate: 2.5% OR counselling only: 1.73 Incremental OR NRT gum (relative to counselling only): 1.63 Incremental OR NRT patch (relative to counselling only): 1.79 Incremental OR NRT spray (relative to counselling only): 2.35 Incremental OR NRT inhaler (relative to counselling only): 2.14 Incremental OR bupropion (relative to counselling only): 2.30 % of smokers still under treatment after the first month: 50% (range 40-60% in sensitivity analysis) % of smokers still under treatment after the second month: 20% (range 15-25% in sensitivity analysis) Lifetime relapse probability after one year of abstinence: 35% (range 10-50% in sensitivity analysis) Effect of smoking cessation on mortality derived from the results of the American Cancer Society Prevention Study II. The mortality rate for former smokers was projected by calculating a weighted average of the incremental differentials between mortality rates of neversmokers and smokers, weighted according to the duration of abstinence.
Spontaneous cessation rate: 2.5% OR counselling only: 1.73 Incremental OR NRT gum (relative to counselling only): 1.63 Incremental OR NRT patch (relative to counselling only): 1.79 Incremental OR NRT spray (relative to counselling only): 2.35 Incremental OR NRT inhaler (relative to counselling only): 2.14 Incremental OR Buproprion (relative to counselling only): 2.30 % of smokers still under treatment after the first month: 50% (range 40-60% in sensitivity analysis) % of smokers still under treatment after the second month: 20% (range 15-25% in sensitivity analysis) Lifetime relapse probability after one year of abstinence: 35% (range 10-50% in sensitivity analysis) Effect of smoking cessation on mortality derived from the results of the American Cancer Society Prevention Study II. The mortality rate for former smokers was projected by calculating a weighted average of the incremental differentials between mortality rates of neversmokers and smokers, weighted according to the duration of abstinence.

“shows that between 1,1 and 1,2 million Belgians have suffered a depressive disorder in the course of their lives, with almost 400 000 having done so in the course of the last twelve months”. )
Si on extrapole ces données au niveau de la population belge, « cela signifie qu’entre 1,1 et 1,2 millions de Belges ont souffert d’un trouble dépressif au cours de leur vie, dont presque 400.000 au cours des 12 derniers mois ».

According to this study, 13,6% of the respondents mentioned their having suffered a depressive disorder (a subcategory of mood disorders) in the course of their lives, 4,6% of which occurred in the twelve last months preceding the survey. Extrapolating these data to the Belgian population “signifie qu’entre 1,1 et 1,2 millions de Belges ont souffert d’un trouble dépressif au cours de leur vie, dont presque 400 000 au cours des 12 derniers mois” (i.e.
D’après cette étude, 13,6 % des répondants rapportent la présence d’un trouble dépressif (souscatégorie des troubles de l’humeur) au cours de leur vie, dont 4,6 % les 12 derniers mois précédant l’enquête.